Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -30.69% vs 95.10% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 44.00% vs 47.06% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 179.80% vs 57.14% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 78.52% vs 137.26% in Mar 2025
Compare Balance Sheet Results of Aptus Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.86
18.15
-11.29
-62.20%
Share Warrants & Outstandings
Total Reserve
16.49
18.00
-1.51
-8.39%
Shareholder's Funds
23.35
36.15
-12.80
-35.41%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.52
0.00
0.52
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.52
0.00
0.52
0.00%
Deferred Tax Assets / Liabilities
-0.09
-0.18
0.09
50.00%
Other Long Term Liabilities
0.36
0.23
0.13
56.52%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.79
0.05
0.74
1,480.00%
Current Liabilities
Trade Payables
8.15
29.42
-21.27
-72.30%
Other Current Liabilities
4.49
4.29
0.20
4.66%
Short Term Borrowings
6.66
0.22
6.44
2,927.27%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
19.31
33.92
-14.61
-43.07%
Total Liabilities
43.44
70.12
-26.68
-38.05%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
4.04
24.50
-20.46
-83.51%
Less: Accumulated Depreciation
1.28
5.74
-4.46
-77.70%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.77
18.76
-15.99
-85.23%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
1.83
-1.83
-100.00%
Other Non Current Assets
5.44
0.50
4.94
988.00%
Total Non-Current Assets
8.21
21.10
-12.89
-61.09%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
13.57
13.22
0.35
2.65%
Sundry Debtors
18.76
32.44
-13.68
-42.17%
Cash and Bank
1.03
1.91
-0.88
-46.07%
Other Current Assets
0.09
0.69
-0.60
-86.96%
Short Term Loans and Advances
1.79
0.77
1.02
132.47%
Total Current Assets
35.24
49.02
-13.78
-28.11%
Net Current Assets (Including Current Investments)
15.93
15.10
0.83
5.50%
Total Current Assets Excluding Current Investments
35.24
49.02
-13.78
-28.11%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
43.44
70.12
-26.68
-38.05%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.18
0.22
6.96
3,163.64%
Book Value per share (adjusted)
13.61
19.91
-6.30
-31.64%
Annual - Borrowings
Borrowings 7.18 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -30.69% vs 95.10% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.36 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 44.00% vs 47.06% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.77 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 179.80% vs 57.14% in Mar 2025
Annual - Investments
Investments 0.00 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 35.24 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 78.52% vs 137.26% in Mar 2025
Footer loading
